Spots Global Cancer Trial Database for rectal cancer stage iii
Every month we try and update this database with for rectal cancer stage iii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. | NCT03561142 | Rectal Cancer Rectal Neoplasm... Rectal Cancer S... Rectal Cancer S... | Radiotherapy Chemotherapy Deep regional h... | 18 Years - | University Hospital Tuebingen | |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | NCT03602079 | HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin... | A166 | 18 Years - | Klus Pharma Inc. | |
| Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. | NCT03561142 | Rectal Cancer Rectal Neoplasm... Rectal Cancer S... Rectal Cancer S... | Radiotherapy Chemotherapy Deep regional h... | 18 Years - | University Hospital Tuebingen | |
| UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | NCT05148767 | Rectal Cancer S... | Neoadjuvant che... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | NCT05148767 | Rectal Cancer S... | Neoadjuvant che... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Using Artificial Intelligence to Predict Rectal Cancer Outcomes | NCT05723965 | Rectal Cancer S... | As training mat... As materials fo... | 20 Years - 100 Years | Taichung Veterans General Hospital | |
| Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer | NCT04970498 | Rectal Cancer S... Rectal Cancer S... | MRI blood routine t... | - | Peking University Third Hospital | |
| TNT to Increase the Clinical Complete Response Rate for Distal LARC | NCT03840239 | Rectal Cancer Rectal Cancer S... Rectal Cancer S... Chemoradiation | Capecitabine, O... External beam r... Surgery Watch and wait ... | 18 Years - 70 Years | Sun Yat-sen University | |
| Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | NCT03391843 | Rectal Cancer S... | FOLFOXIRI+Cetux... | 18 Years - 75 Years | RenJi Hospital | |
| Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer | NCT04970498 | Rectal Cancer S... Rectal Cancer S... | MRI blood routine t... | - | Peking University Third Hospital | |
| The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer | NCT04598984 | Rectal Cancer S... | serum adipokine... | 18 Years - | Istanbul Training and Research Hospital | |
| TNT to Increase the Clinical Complete Response Rate for Distal LARC | NCT03840239 | Rectal Cancer Rectal Cancer S... Rectal Cancer S... Chemoradiation | Capecitabine, O... External beam r... Surgery Watch and wait ... | 18 Years - 70 Years | Sun Yat-sen University | |
| Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | NCT03391843 | Rectal Cancer S... | FOLFOXIRI+Cetux... | 18 Years - 75 Years | RenJi Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
